C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
530/13, 195/1.22
C12N 15/12 (2006.01) A61K 38/17 (2006.01) C07K 14/73 (2006.01) C12N 1/21 (2006.01) C12N 5/10 (2006.01)
Patent
CA 2017389
ALTERATION OF ABILITY OF SOLUBLE CD4 PROTEIN TO BIND CLASS II MHC ANTIGENS Abstract of the Disclosure The present invention pertains to biologically active, modified soluble human CD4 surface glycoprotein fragments having a decreased affinity (compared to naturally occurring human CD4) for major histocompatibility class II antigens but which are capable of binding to the HIV gp120 envelope protein. The soluble CD4 fragments have the ability to inhibit HIV binding to naturally occurring CD4 surface receptors but will not inhibit class II MHC recognition events.
Clayton Linda K.
Reinherz Ellis L.
Borden Ladner Gervais Llp
Clayton Linda K.
Dana Farber Cancer Institute
Reinherz Ellis L.
LandOfFree
Alteration of ability of soluble cd4 protein to bind class... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alteration of ability of soluble cd4 protein to bind class..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alteration of ability of soluble cd4 protein to bind class... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1466078